Valye reports for unlimited access

DSwiss Inc is a biotech nutraceutical firm incorporated in Nevada in 2015, operating through wholly-owned subsidiaries in Seychelles, Hong Kong, and Malaysia. The company specializes in turnkey private label manufacturing (OEM/ODM) of premium healthcare, skincare, and personal care products using natural ingredients. Its product range includes functional foods, health supplements, skincare, personal care, pet wellness products, traditional medicines, and meal replacements. DSwiss emphasizes quality and innovation, adhering to GMP, HACCP, JAKIM Halal, ISO, and MESTI standards. The company serves markets across Asia-Pacific and is expanding globally through strategic marketing, social media, and trade show participation. It reported $2.9 million revenue in 2025, mainly from OEM/ODM sales, with a net loss of $76,860. DSwiss is actively pursuing mergers and acquisitions to complement organic growth and enhance its capabilities [S1].

Professional Diversity Network, Inc. is a holding company operating three primary business units: TalentAlly, LLC; NAPW, Inc.; and RemoteMore USA, Inc. The company focuses on providing professional networking and recruitment solutions targeted at diverse professionals across multiple affinity groups, including women, ethnic minorities, persons with disabilities, military professionals, and LGBTQ+ communities. Its TalentAlly Network offers online job seeker communities and recruitment advertising services, leveraging AI technology and partnerships with diversity-based organizations to connect job seekers with employers. The company also organizes online and in-person diversity career fairs. In 2025, it initiated a strategic transformation to expand into Web3.0, copyrights, digital assets, and real-world asset platforms, including a consultancy agreement with Deeptrade PTY LTD. The company reported narrowing losses in its RemoteMore segment and continues to develop operational efficiencies and AI integration in its platforms. It maintains a cybersecurity risk management program and faces Nasdaq compliance challenges [S1][N1][N3][N4][N5].

Hashdex Commodities Trust is a Delaware statutory trust established in 2023, currently operating a single series: the Hashdex Bitcoin ETF (DEFI). The Fund aims to provide investors with exposure to bitcoin price movements by tracking the Nasdaq Bitcoin Reference Price - Settlement benchmark. It holds primarily physical bitcoin, with a policy to maintain at least 95% of assets in bitcoin and up to 5% in cash. Shares trade on NYSE Arca and are created and redeemed in baskets by authorized financial institutions. The Fund transitioned from a bitcoin futures-based strategy to direct spot bitcoin holdings in March 2024. Hashdex Asset Management Ltd. became the Fund's sponsor in January 2026, replacing Tidal Investments LLC. The Fund's assets are custodied by BitGo Trust Company for bitcoin and U.S. Bank for cash. The Fund pays a 0.25% annual management fee and incurs brokerage and transaction fees related to bitcoin trading. The Fund's NAV is calculated daily based on the benchmark price, with procedures for fair valuation if needed. The Fund's shares are held in book-entry form through the Depository Trust Company.

Massimo Group operates as a U.S.-based manufacturer, importer, and distributor of utility-focused and recreational powersports vehicles and marine products. Its product range includes utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), golf carts, scooters, motorcycles, youth products, and pontoon boats. The company focuses on practical, utility-driven mobility solutions designed for year-round use, particularly emphasizing all-weather, fully enclosed, HVAC-equipped vehicles such as the Sentinel series. Massimo serves rural, agricultural, commercial, and recreational markets through a nationwide dealer and retail network, including partnerships with major retailers and an e-commerce platform integrated with dealer fulfillment. The company operates a 376,000 sq. ft. facility in Dallas, Texas, which houses assembly lines, design and testing centers, parts distribution, and logistics infrastructure. Strategic initiatives include expanding all-weather vehicle offerings, enhancing distribution and omnichannel sales capabilities, developing commercial and fleet sales channels, diversifying the supply chain, and investing in operational efficiency and technology integration, including AI and intelligent systems. Massimo's business model leverages a combination of internal manufacturing, global supplier partnerships, and a broad service network to support growth and customer satisfaction.

Canton Strategic Holdings, Inc. is a publicly traded company pioneering institutional adoption of blockchain technology through its focus on Canton Coin (CC) and the Canton Network. Initially a biotechnology company developing therapeutic candidates, it shifted its core strategy in November 2025 to prioritize digital asset treasury management and investment in the Canton Network ecosystem. The company operates as a Super Validator, earning protocol rewards and supporting network security, while also investing in applications and middleware that enhance capital markets transactions on the network. It actively participates in governance via the Canton Foundation and manages its CC holdings with institutional custodians. The Canton Network is a public, permissionless blockchain designed for institutional privacy and interoperability, processing trillions in tokenized assets. The company’s financials reflect ongoing net losses and a strong liquidity position as of the end of 2025.

NeuroSense Therapeutics Ltd. is an Israeli clinical-stage biopharmaceutical company specializing in the development of treatments for neurodegenerative diseases, including ALS, Alzheimer's disease, and Parkinson's disease. The company’s lead product candidate is PrimeC, which is under clinical investigation. NeuroSense has no approved products or revenues and funds its operations primarily through shareholder financing. The company’s shares and warrants have been publicly traded on the Nasdaq Capital Market since December 2021. Its financial statements are prepared under U.S. GAAP, with the U.S. dollar as the functional currency. The company reported a net loss of $11.125 million for the year ended December 31, 2025, and held limited cash and current assets relative to liabilities, indicating liquidity constraints. NeuroSense continues to advance its clinical programs and has recently reported favorable safety data for PrimeC in an Alzheimer's study. The company’s business is subject to risks common to early-stage pharmaceutical developers, including the need for additional capital to fund its development pipeline.

RADCOM LTD develops and delivers software solutions and services that provide real-time data analytics and subscriber intelligence for mobile and fixed networks. The company operates globally with subsidiaries in the US, Canada, India, and Brazil. Its business model relies heavily on a limited number of major customers, which accounted for 86% of revenues in 2025. RADCOM maintains multi-year agreements with key customers such as AT&T and Rakuten, covering software, professional services, and managed services including 5G network support. The company reported $71.5 million in total revenues for 2025, with a balanced split between product sales and services. It holds strong liquidity with a current ratio of 5.75 as of year-end 2025. Shareholder structure includes institutional investors and insiders, with no single executive owning more than 1% of shares. RADCOM does not pay dividends, retaining earnings for growth and operations [S1].

Check Point Software Technologies Ltd. operates as a global cybersecurity provider, offering AI-powered solutions to protect digital assets and trust for over 100,000 organizations worldwide. Its Infinity Platform employs a hybrid mesh network architecture with SASE technology to unify security management across on-premises, cloud, and workspace environments. The company’s revenue model includes product and license sales, security subscriptions, and software updates and maintenance, primarily delivered through indirect channels such as distributors, resellers, OEMs, system integrators, and managed security service providers. Geographically, its revenues are diversified across the Americas, EMEA, and Asia-Pacific regions. Check Point emphasizes a prevention-first approach and integrates AI-driven security features to address evolving cyber threats. The company maintains robust cybersecurity governance and risk management programs overseen by its Board and senior management.

Gogoro Inc. is a company engaged in the design, manufacture, and sale of electric scooters and the provision of battery swapping services. The company operates a network of subsidiaries and joint ventures across Taiwan, India, and other markets. Its business model includes sales of electric scooters, battery swapping services billed through various plans, and maintenance and leasing services. Gogoro recognizes revenue when control of scooters transfers to customers and over time for service contracts. The company manages credit risk through creditworthiness assessments and expected credit loss provisions. As of December 31, 2025, Gogoro reported total assets of approximately $601.6 million and total liabilities of $493.3 million, with equity of $108.2 million. The company has a history of net losses and operates under IFRS accounting standards. Leadership includes CEO Henry Chiang, CFO Bruce Aitken, and Chairman Tamon Tseng. Gogoro maintains an equity incentive plan for employees and directors and has recently secured a significant equity investment from a major shareholder.

ATA Creativity Global operates as a holding company with its primary business conducted through subsidiaries and a VIE in China. The company offers educational services including portfolio training, research-based learning, overseas study counseling, and other educational services. Revenue recognition follows ASC 606 principles, with revenue recognized over time based on service delivery and costs incurred. The company faces regulatory restrictions on foreign ownership of internet content provision services in China, which it addresses through contractual VIE arrangements. Financially, the company has reported net losses and liquidity constraints but has raised capital through financing rounds to support ongoing operations. The company's ADSs are listed on Nasdaq and are considered readily tradable in the U.S. market [S1].

Radware Ltd., founded in 1996 and headquartered in Tel Aviv, Israel, specializes in application security and delivery solutions tailored for multi-cloud environments. Its product portfolio includes hardware and software solutions, cloud-based DDoS protection, cloud application protection subscriptions, and post-contract customer support services. The company distributes its products primarily through resellers and distributors worldwide, with significant operations in North America, EMEA, and Asia-Pacific. Radware has expanded its capabilities through acquisitions such as Pynt, Inc. (API security testing) and DC Security Ltd. (cloud DDoS network operator). The company reported $301.85 million in revenues for 2025, reflecting growth in cloud security offerings and hardware sales, particularly in the EMEA region. Radware's financial statements are prepared in U.S. dollars and comply with U.S. GAAP. The company maintains a strong liquidity position and continues to invest in R&D and sales and marketing to support its growth and product innovation.

BW LPG Ltd is a company engaged in the transportation and trading of liquefied petroleum gas (LPG). Its business is divided into two main segments: Shipping and Product Services. The Shipping segment operates a fleet of LPG vessels that generate revenue through spot voyages and time charters. The majority of these vessels participate in a pool arrangement that facilitates marketing and revenue sharing among vessel owners. Product Services involves trading activities including the sale of LPG cargo and managing derivative contracts to hedge price and freight rate fluctuations. The company has long-term supply contracts and spot sales contracts with customers, and coordinates with Shipping through contracts of affreightment to utilize fleet capacity. BW LPG expanded its Product Services segment by acquiring Vilma Oil’s LPG trading operations in 2022. The company’s fleet utilization was 94% in 2025, slightly lower than 2024, affected by maintenance and commercial factors. Financially, BW LPG reported net income of $289.7 million for 2025, with earnings per share of $1.60. Operating profit decreased from the prior year, impacted by higher operating expenses and increased interest costs due to fleet acquisitions and refinancing. The company maintains liquidity with a current ratio of 1.53 and cash ratio of 0.58 as of year-end 2025. BW LPG’s business is influenced by seasonal demand variations, geopolitical events, and LPG production and export trends. The company complies with financial covenants and manages risks through hedging and operational strategies. Its shares trade on the NYSE and Oslo Stock Exchange.

Alvotech is a global biopharmaceutical company focused on developing and manufacturing biosimilar medicines to improve patient access to biologic treatments. Founded in 2013, the company has built a platform with experienced leadership, a broad pipeline of biosimilar candidates, and partnerships for commercialization. Its approved products include AVT02 (adalimumab) and AVT04 (ustekinumab), with additional candidates targeting major therapeutic areas such as autoimmune diseases, eye disorders, bone diseases, and cancer. Alvotech generates revenue from product sales, licensing, milestone payments, and supply agreements. The company’s financial position as of late 2025 reflects growing revenues, profitability, and liquidity supported by equity and debt financing.

BlockchAIn Digital Infrastructure, Inc. was incorporated in Delaware in April 2025 and completed a business combination in March 2026 involving Signing Day Sports and One Blockchain, with One Blockchain becoming the primary operating subsidiary. One Blockchain focuses on developing and operating digital infrastructure dedicated to AI hosting and high-performance computing workloads. Its main asset is a 40 MW data center facility in Spartanburg County, South Carolina, one of the largest single-site data center hosting facilities in the state. The company is transitioning its customer base toward AI and HPC workloads and is developing modular deployment architecture to convert power-secured sites into AI-ready infrastructure. Strategic collaborations with PDM and Super Micro support electrical infrastructure and AI hardware deployment. The company has non-binding arrangements with global cloud providers for potential build-to-suit leases totaling 25 MW. Growth plans include expanding the South Carolina facility to 50 MW and developing a 25 MW AI-focused site in Minnesota, with a broader development pipeline across multiple U.S. markets. The company operates an owner-agnostic hosting model, providing physical infrastructure and power delivery under long-term contracts. It maintains a capital-efficient business model with no significant traditional debt and positive equity. The management team has deep industry expertise. Customer concentration, reliance on a single power provider, and regulatory risks are material considerations.

Brookfield Business Corp is a financial services company operating in the asset management industry with diversified operations including construction, dealer software and technology services, and Brazilian water and wastewater services. The company generates revenues primarily from contracts with customers across multiple geographies, notably Australia, the United States, the United Kingdom, and Brazil. It maintains a significant backlog of construction projects and long-term service concession arrangements, providing multi-year revenue visibility. The company’s capital structure includes non-recourse borrowings and equity instruments, with management services provided by its ultimate parent company under a Master Services Agreement. The company underwent a corporate reorganization in early 2026, resulting in a name change and delisting of the original entity.

Brookfield Business Corporation, formerly Brookfield Business Partners L.P. (BBU), is a global industrial and business services conglomerate operating primarily in the United States, Europe, Australia, Brazil, and Canada. The company focuses on owning and operating high-quality business services, infrastructure services, and industrial operations that provide essential products and services with strong competitive positions. Its operating segments include business services (such as dealer software, mortgage insurance, fleet management, construction, and payment processing), infrastructure services (including modular building leasing, lottery services, offshore oil services, and work access services), industrials (advanced energy storage, engineered components manufacturing, water and wastewater, electric heat tracing systems), and corporate activities. The company pursues an operations-oriented acquisition strategy and recycles capital from operations and dispositions into existing operations and new acquisitions. As of December 31, 2025, the company reported total assets of $75.8 billion and revenues of $27.5 billion. The company was incorporated in October 2025 and completed a corporate reorganization in March 2026, becoming a subsidiary of Brookfield Business Corporation and delisting from public markets.

Rezolve AI PLC is a technology company headquartered in London, United Kingdom. The company filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, disclosing financial results including a net loss and liquidity metrics. In early 2026, Rezolve AI completed a significant $250 million registered direct offering to institutional investors, aimed at funding sales expansion, potential acquisitions, and general corporate purposes. Subsequently, the company acquired Reward Loyalty UK Limited, a UK-based loyalty platform, for approximately $230 million in cash. The CEO and Chairman, Daniel Wagner, has overseen these strategic initiatives. Public disclosures and news coverage indicate active capital raising and acquisition activity, with notable stock price movements in response to these events.

BGSF, Inc. operates as a national staffing and workforce solutions company focused on the Property Management industry in the United States. The company provides field talent for maintenance and office functions to property management companies managing apartment communities and commercial buildings. Its services include on-demand, short-term assignments and direct hire placements, enabling clients to manage workforce variability and convert fixed personnel costs to variable expenses. BGSF retains employment responsibility for its field talent while client partners supervise daily work. The company has grown organically in its core Property Management segment and divested its Professional and Light Industrial segments in recent years to focus on this market. BGSF employs internal team members and places thousands of field talent annually. It invests in technology, including AI tools, to enhance recruiting and onboarding. The company faces a highly competitive and fragmented market with seasonal demand fluctuations and economic sensitivity. Marketing efforts span digital platforms and partnerships, supported by diversity and community engagement initiatives.

Peraso Inc. operates as a fabless semiconductor company focused on the development and sale of millimeter wave (mmWave) wireless technology semiconductor devices and antenna modules, as well as non-recurring engineering services and intellectual property licensing. Its mmWave products primarily operate in the 24 GHz to 71 GHz frequency bands and enable applications such as multi-gigabit point-to-point and point-to-multi-point wireless links, fixed wireless access (FWA) including 5G bands, military communications, and consumer applications like high-performance wireless video streaming and augmented/virtual reality. The company discontinued its memory IC product line in 2023 due to foundry process discontinuation and fulfilled all outstanding orders by March 2025. Peraso’s products include integrated mmWave ICs and antenna modules (PERSPECTUS family) with proprietary beamforming technology and a user arbitration protocol (DUNE) to optimize network performance in dense urban environments. The company’s customer base includes OEMs and wireless internet service providers, with revenue highly concentrated among a few customers. Peraso reported $14.573 million in revenue and a net loss of $4.753 million for the fiscal year ended December 31, 2025, with cash and equivalents of $2.886 million and a current ratio of 4.14. It faces risks related to capital needs, customer concentration, and industry cyclicality, and is currently exploring strategic alternatives including a potential acquisition proposal [S1][S2].

Curanex Pharmaceuticals Inc is a clinical-stage pharmaceutical company developing Phyto-N, a botanical drug candidate targeting ulcerative colitis and potentially other indications. The company shifted focus in 2023 from health supplements to botanical drug development. Phyto-N is in early development, with plans for FDA-required studies and clinical trials. The company has no commercial products or revenues and relies on external financing to fund operations. Intellectual property includes provisional patents acquired from Duraviva and a PCT application filed to secure broader patent protection. Manufacturing is outsourced to third parties. The company became a public SEC reporting entity following its IPO and incurs related compliance costs.

SoundThinking, Inc. is a Nasdaq-listed company with recent financial disclosures indicating ongoing net losses and liquidity challenges as of the end of 2025. The company maintains a revolving credit facility extended through 2027. It has a structured cybersecurity risk management program overseen by senior management and the board's audit committee. Public information includes quarterly earnings releases and analyst coverage with buy and outperform recommendations. Detailed descriptions of the company's products, services, or industry focus are not explicitly disclosed in the available SEC filings or news reports.

zSpace, Inc. develops and sells augmented and virtual reality educational technology products, focusing on interactive 3D learning experiences without the need for VR goggles. Its business model includes sales of proprietary hardware such as the Inspire laptop, software licenses and subscriptions for STEM and CTE applications, and professional development services. The company primarily serves U.S. K-12 schools, career and technical education sectors, and select international markets. Revenue is recognized at the point of hardware shipment and over contract terms for software licenses. zSpace faces long sales cycles due to the bureaucratic nature of school district purchasing and is sensitive to fluctuations in government education budgets. The company has strategic manufacturing partnerships with major PC OEMs and relies on third-party suppliers for components. It tracks bookings, annual contract value, and customer retention metrics to monitor business performance. zSpace’s common stock began trading publicly in December 2024 [S1].

American Eagle Outfitters, Inc. (AEO) is a leading global specialty retailer with a portfolio of apparel brands including American Eagle, Aerie, OFFLINE by Aerie, Todd Snyder New York, and Unsubscribed. The company operates and licenses nearly 1,500 retail stores worldwide, primarily in the U.S., Canada, and Mexico, and sells products through online platforms and concession-based shops. AEO emphasizes omni-channel retailing, integrating physical stores with digital channels to enhance customer experience and operational efficiency. The company maintains a customer loyalty program, Real Rewards, to drive engagement and lifetime value. Merchandise is designed internally and sourced from third-party factories mainly in Asia, with quality and compliance programs in place. AEO's fiscal year ends near January 31, with the latest financial snapshot showing solid liquidity and profitability. The company focuses on amplifying its brands, financial discipline, and operational optimization as key strategic priorities.

Live Oak Acquisition Corp. V is a Cayman Islands exempted blank check company formed in November 2024 to effect a business combination with one or more businesses. It completed its IPO in March 2025, raising gross proceeds of $23 million from 23 million units and $4.5 million from private placement warrants. The company focuses on acquiring businesses with enterprise values between $500 million and $2 billion that have strong growth prospects, free cash flow generation, and defensible market positions. The management team has extensive prior SPAC experience. The company has no operating revenues and reported a net loss of $16.5 million for the fiscal year ended December 31, 2025. It held $1.33 million in cash and had a current ratio of 1.27 at year-end 2025. Live Oak V has entered into a definitive merger agreement with Teamshares, a tech-enabled acquiror of high-quality SMEs with over $400 million in revenue. The merger consideration values Teamshares at $525 million plus interim financing, with additional earnout shares contingent on share price targets over five years. The transaction includes a $126 million PIPE financing led by T. Rowe Price affiliates. The company must complete its business combination by March 3, 2027, or liquidate and return funds to shareholders.

WinVest Acquisition Corp. is a special purpose acquisition company (SPAC) incorporated in Delaware in 2021. Its business model centers on identifying and completing an Initial Business Combination with one or more target companies, initially focusing on scalable digital financial media and investing platforms but open to other sectors. The company has not generated operating revenues and remains in the pre-combination phase. It raised approximately $115 million in its IPO, held in a Trust Account to be used for the business combination. Management and advisory teams have experience in digital financial services and acquisitions. The company’s securities were delisted from Nasdaq in March 2025 due to failure to complete a business combination within the required timeframe and now trade on OTC Markets with limited liquidity. The deadline for completing a business combination has been extended multiple times, most recently to April 17, 2025. A prior proposed combination with Xtribe PLC was terminated, and a new agreement with Embed Financial Group Holdings has not yet closed. The company’s financial position as of December 31, 2025, shows net losses, minimal operating cash, significant current liabilities, and a small remaining Trust Account balance.

Bio Green Med Solution, Inc. is a company engaged in the fire safety industry, operating through its wholly-owned subsidiary Fitters Sdn. Bhd., a Malaysia-based company established in 1982. The subsidiary specializes in supplying and trading a broad range of fire safety products including fire equipment, foam systems, fire resistant doors, personal protective equipment, and fire safety apparel. The company’s revenue is primarily derived from trading and installation of fire safety materials and equipment, with demand influenced by industrialization, urbanization, and safety awareness trends. The company completed a transaction in 2025 acquiring Fitters as a wholly-owned subsidiary, issuing shares to FITTERS Diversified Berhad as part of the consideration. The business faces competitive pressures, customer concentration risks, and operational challenges related to integration and market conditions. Financially, the company reported no revenue and a net loss for the fiscal year ended December 31, 2025, with a strong liquidity position but substantial doubt about its ability to continue as a going concern without additional capital.

KRAKacquisition Corp is a Cayman Islands exempted blank check company incorporated in July 2025. Its primary purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on companies in the digital asset ecosystem, particularly those bridging decentralized finance (DeFi) and traditional finance (TradFi), including payment networks, tokenization platforms, blockchain infrastructure, and compliance solutions. The company completed its Initial Public Offering in January 2026, raising gross proceeds of $345 million, which are held primarily in a Trust Account. The company currently has no operations and nominal assets consisting almost entirely of cash. It plans to use the IPO proceeds, private placement shares, equity, debt, or a combination thereof to complete its initial Business Combination. The company has reviewed multiple potential targets but has not yet completed any acquisition. Its Sponsor includes Payward, Inc. (d/b/a Kraken), Tribe Capital, and Natural Capital, providing expertise in crypto platforms, fintech venture capital, and SPACs. The company pays its Sponsor monthly fees for office and administrative support. The company is subject to risks typical of blank check companies, including dependence on a single business post-acquisition, limited ability to evaluate target management, and competition for acquisition targets.

Akari Therapeutics Plc is a clinical-stage oncology company focused on developing next-generation antibody-drug conjugates (ADCs) that utilize a novel proprietary payload, PH1, which modulates the spliceosome to disrupt RNA splicing in cancer cells. This disruption leads to direct cytotoxicity and the generation of neoantigens that activate the immune system, potentially enhancing cancer cell killing. The lead ADC candidate, AKTX-101, targets the Trop-2 receptor and has demonstrated superior preclinical efficacy and potential synergy with checkpoint inhibitors. The company is preparing for a first-in-human Phase 1 trial for AKTX-101, with GMP manufacturing underway. A second ADC program, AKTX-102, targets CEACAM5 and is in earlier discovery stages. Akari's strategy includes advancing its pipeline, leveraging partnerships for development and commercialization, and protecting its intellectual property through patents in multiple jurisdictions. The company currently has no approved products and has incurred operating losses, relying on equity financing to support its research and development activities.

Actinium Pharmaceuticals is focused on pioneering targeted radiotherapies to address unmet medical needs in oncology. The company develops first-in-class radiopharmaceutical therapeutics by integrating tumor biology insights with radiochemistry expertise. Its pipeline targets novel antigens in solid tumors and hematologic cancers, including ATNM-400 for solid tumors and Actimab-A for both solid tumors and hematologic malignancies. The company also develops targeted conditioning agents Iomab-B and Iomab-ACT for bone marrow transplant and cell & gene therapies. Actinium has conducted extensive clinical trials involving over 500 patients and is establishing a vertically integrated manufacturing and supply chain infrastructure, including a new cGMP facility expected to be operational in 2H 2026. The company holds a robust intellectual property portfolio and is actively pursuing strategic partnerships to advance its late-stage programs.

Lexeo Therapeutics, Inc. is focused on developing gene therapies using a novel non-viral RNA platform, targeting hereditary and acquired diseases with significant unmet medical needs, especially in cardiovascular indications. The company engages in collaborations and partnerships to advance its therapeutic programs, including a notable collaboration with Abiomed, Inc. to explore targeted cardiac gene therapy delivery. Lexeo operates as a single reportable segment and manages its operations primarily in the United States. The company is in the clinical and preclinical stages of product development and has not reported commercial revenues.

Siebert Financial Corp. is a diversified financial services company with operations across brokerage, investment advisory, insurance, technology, media, sports, and entertainment sectors. The company operates through several subsidiaries including Muriel Siebert & Co., LLC (retail brokerage), Siebert AdvisorNXT, LLC (investment advisory), Park Wilshire Companies, Inc. (insurance), Siebert Technologies, LLC (technology development), RISE Financial Services, LLC (broker-dealer), Gebbia Media, LLC (media and talent management), and Siebert Crypto, LLC (digital asset services, not yet operational). The company manages its business as two reportable segments: Financial Services and Media, Sports and Entertainment. It has a history of technology investments aimed at enhancing client experience and operational efficiency. The company has expanded its leadership team and launched new initiatives such as an investment banking division targeting middle-market clients. Siebert Financial Corp. common stock trades on the Nasdaq Capital Market under the ticker SIEB.

LGL Group Inc is a holding company engaged in diversified business activities including manufacturing, services, and merchant investments. It operates primarily through two segments: Electronic Instruments, via its subsidiary Precise Time and Frequency, LLC (PTF), which designs and manufactures high-performance time and frequency reference products; and Merchant Investment, which involves various investment vehicles and capital deployment strategies. The company pursues growth through acquisitions, partnerships, and strategic investments, focusing on undervalued companies and long-term value creation. It maintains a strong balance sheet and liquidity position, supporting its investment and operational activities.

Pathfinder Bancorp, Inc. is a bank holding company incorporated in 2014 and headquartered in Oswego, New York. It wholly owns Pathfinder Bank, a New York-chartered commercial bank regulated by the Federal Reserve Board and the New York State Department of Financial Services. The bank operates 13 branches primarily in Oswego and Onondaga Counties, serving individuals, families, small to mid-size businesses, and municipalities. The company reported total consolidated assets of $1.43 billion and shareholders' equity of $122.5 million as of December 31, 2025. Its loan portfolio includes commercial real estate, commercial business loans, residential real estate loans, municipal loans, home equity loans, and consumer loans. The bank focuses on community banking with local decision-making and competitive pricing. It holds a significant market share in Oswego County deposits and faces competition from banks, credit unions, and fintech companies. The company also owns subsidiaries involved in real estate development and insurance brokerage, though the latter is currently inactive. Recent financial results indicate a return to profitability in 2025 after prior losses.

Pyrophyte Acquisition Corp. II is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands, formed to identify and complete an initial Business Combination with a target operating business. The company completed its IPO in July 2025, issuing units consisting of Class A Ordinary Shares and warrants, raising gross proceeds of $175 million. Funds from the IPO are held in a Trust Account to be used for the Business Combination. The Sponsor holds Founder Shares and Private Placement Warrants acquired at nominal cost, which convert into Class A Ordinary Shares upon the Business Combination, resulting in dilution to Public Shareholders. The company currently has no operations or revenues and generates income primarily from interest on trust assets. It has a 24-month period from the IPO to complete the Business Combination or else must liquidate and redeem Public Shares. The company is subject to risks related to dilution, governance under Cayman Islands law, and potential conflicts of interest with the Sponsor. It is an emerging growth company and benefits from certain regulatory exemptions.

Glucotrack, Inc. is a Delaware-based medical device company focused on developing an implantable continuous blood glucose monitor (CBGM) for people with Type 1 diabetes and insulin-using Type 2 diabetes or those at risk for hypoglycemia. The company previously developed a non-invasive glucose monitor but ceased its commercialization in 2023 to focus on the CBGM. The Glucotrack CBGM uses an intravascular implant connected to a lead placed in a blood vessel, enabling continuous glucose measurement with minimal lag time compared to interstitial fluid CGMs. Preclinical studies have demonstrated sensor longevity of at least two years, with modeling supporting three-year feasibility. The company completed a first-in-human acute study in 2025, meeting safety and performance goals, and initiated a long-term clinical study in Australia, which was later closed to prioritize a U.S. clinical trial program. Discussions with the FDA are ongoing, with an IDE submission planned for the second quarter of 2026. Glucotrack holds ISO 13485 certification and has a management team with extensive experience in diabetes device development. The company faces competition from established CGM manufacturers and continues to invest in clinical development and regulatory approvals.

Camber Energy, Inc. operates as a diversified technology company focusing on innovative and patented technologies in waste treatment, electric transmission safety, and clean energy. Its portfolio includes a majority interest in Viking Ozone, which owns a patented medical and bio-hazard waste treatment system using ozone technology, designed as a sustainable alternative to traditional waste disposal methods. The VKIN-300 unit has achieved significant regulatory progress in France. The company also holds majority interests in entities owning patented electric transmission and distribution broken conductor protection systems aimed at enhancing grid safety and reliability. Additionally, Camber has an exclusive license for a patented clean energy and carbon-capture system in Canada and parts of the US, with multiple patents issued and pending. Camber owns a 49% interest in Simson-Maxwell Ltd., a Canadian custom energy and power solutions provider offering CHP, diesel and natural gas engines, solar, wind, and storage products. Following restructuring, Camber operates as a single reporting segment and accounts for its investment in Simson-Maxwell at fair value. The company has several outstanding secured promissory notes and a convertible note with FK Venture. Financially, as of the fiscal year ending 2025, Camber reported $6.23 million in revenue and a net loss of $4.41 million, with liquidity ratios indicating limited short-term financial flexibility.